An efficacious and cost-effective pharmacologic treatment for helicobacter pylori

Sarah Gurney, Laura Carvalho, Carrie Gonzalez, Esperanza Galaviz, Frances Sonstein

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Helicobacter pylori (H.pylori) is a common widespread infection that, if left untreated, is a risk factor for gastric cancer. H.pylori is a contagious disease with a high prevalence in low socioeconomic areas. The multidrug regimen for eradication of H.pylori can be difficult to complete because of medication side effects, confusing dosing regimens, and cost. Thisarticle reviews H.pylori infection pathophysiology, symptoms, screening, and diagnosis. Using the most recent evidence-based research, recommendations have been made toachieve the most efficacious and cost-effective treatment of H.pylori in the primary care setting.

Original languageEnglish (US)
Pages (from-to)22-29
Number of pages8
JournalJournal for Nurse Practitioners
Issue number1
StatePublished - Jan 2014


  • Allergic
  • Cost-effective
  • Eradication
  • Helicobacter pylori
  • Treatment

ASJC Scopus subject areas

  • Advanced and Specialized Nursing


Dive into the research topics of 'An efficacious and cost-effective pharmacologic treatment for helicobacter pylori'. Together they form a unique fingerprint.

Cite this